Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin.

MLA

Shin-Ichi Araki, et al. “Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin.” Diabetes Care, vol. 36, no. 7, July 2013, pp. e92–93. EBSCOhost, https://doi.org/10.2337/dc12-2702.

APA

Shin-Ichi Araki, Hiroyuki Matsuno, Masakazu Haneda, Daisuke Koya, Yosuke Kanno, Shiniji Kume, Keiji Isshiki, Hisazumi Araki, Satoshi Ugi, Hiromichi Kawai, Atsunori Kashiwagi, Takashi Uzu, & Hiroshi Maegawa. (2013). Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin. Diabetes Care, 36(7), e92–e93. https://doi.org/10.2337/dc12-2702

Chicago

Shin-Ichi Araki, Hiroyuki Matsuno, Masakazu Haneda, Daisuke Koya, Yosuke Kanno, Shiniji Kume, Keiji Isshiki, et al. 2013. “Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin.” Diabetes Care 36 (7): e92–93. doi:10.2337/dc12-2702.